Hematologic laboratory changes during post COVID 19 in children

The COVID-19 pandemic has affected millions globally, with a notable impact on pediatric patients. Hematologic and inflammatory changes in children with COVID-19 can provide key insights into disease severity, recovery patterns, and the likelihood of complications. This study investigates the role of specific hematologic markers in predicting clinical outcomes such as length of hospitalization and the presence of respiratory symptoms in pediatric patients’ post-COVID-19. Descriptive analysis showed that 67.1% of patients presented with respiratory symptoms, while 47.1% had elevated neutrophil levels, 57.9% had low lymphocyte levels, and 55% had high CRP levels. Significant associations are identified between elevated neutrophil with longer hospitalization and respiratory complications, while lower lymphocyte and platelet levels were linked to shorter stays.